(Hypertension. 1999;34:508-513.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Division of Hypertension and Vascular Research, Henry Ford Hospital, Detroit, Mich.
Correspondence to Jeffrey L. Garvin, Division of Hypertension and Vascular Research, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202.
| Abstract |
|---|
|
|
|---|
Key Words: absorption, chloride absorption, sodium kidney tubules, collecting cyclic GMP nephron
| Introduction |
|---|
|
|
|---|
Although the cause of the disparate salt absorption by the loops of
Henle of DS and DR is unclear, both P450 metabolites7 and
NO have been implicated.2 8 9 Patel et al2
showed that L-arginine, the substrate for NO synthase
(NOS), restores pressure natriuresis to normal levels in DS. Salazar et
al8 showed that intravenous infusion of
N
-nitro-L-arginine
methyl ester (an NOS inhibitor) confers salt sensitivity in
dogs. Chen and Sanders9 showed that
L-arginine, but not D-arginine, lowered blood
pressure in DS fed a high-salt diet and that a competitive
inhibitor of NOS raised blood pressure more in DR than in
DS. These reports indicate that either production of or
response to NO is diminished in the DS.
Because both the collecting duct and the thick ascending limb have been implicated as expressing a defect in the DS,5 6 we investigated basal rates of transport by cortical and medullary thick ascending limbs and collecting ducts. Also, because a defect in either the synthesis of or the response to NO is implicated in Dahl salt sensitivity9 and NO inhibits nephron transport,10 11 we examined the effect of NO on transport in each segment. We hypothesized that basal transport is greater in thick ascending limbs, whereas inhibition of transport by NO is diminished in DS.
| Methods |
|---|
|
|
|---|
Tubule Perfusion
Male DS and DR that weighed 130 to 150 g (Harlan)
were maintained on a diet that contained 0.2% sodium and 1.1%
potassium (Ralston Purina) for
5 days before use. Rats used for
cortical collecting duct experiments were injected with DOC acetate (5
mg/rat IM) 5 to 9 days before the experiment to enhance sodium
transport.11 Rats were anesthetized with
ketamine (0.1 mg/kg; Parke Davis). The peritoneal cavity was
opened and flushed with cold NaCl (150 mmol/L). The left kidney
was removed and placed in cold dissection medium equilibrated with 95%
O25% CO2. Coronal slices
were transferred to a dissection dish that contained
physiological saline at 6°C to 10°C. Medullary
rays were dissected from the slices, and tubules were dissected from
the rays. Tubules were transferred to a perfusion chamber, mounted on
concentric pipettes, and perfused at 37°C.10 All
protocols were performed in accordance with the guidelines of the Henry
Ford Hospital Animal Care and Use Committee. The composition of the
perfusion solution (in mmol/L) was: NaCl 114.0, KCl 4.0,
NaH2PO4 2.5,
MgSO4 1.2, Na3 citrate 1.0,
NaHCO3 25.0, alanine 6.0, Ca
lactate2 2.0, glucose 5.5, and raffinose 5.0. The
perfusion and bath solutions were generally the same, except that
spermine NONOate (SPM) or nitroglycerin (NTG) was
added to the bath. The osmolality of all solutions was 295±3 mOsmol/L.
The pH of the bath was 7.4. Solutions were gassed with 95%
O25% CO2.
Chloride Absorption
Chloride concentration was measured in samples of the bath,
perfusate, and collected fluid with a newly developed
ultramicrofluorometric assay.12 Net chloride absorption
(JCl) was calculated according to the
equation
![]() |
Sodium Absorption
Sodium concentration was measured in samples of the bath,
perfusate, and collected fluid as described
previously.11 Net sodium flux was calculated with the
equation above.
Suspensions of Inner Medullary Collecting Duct
Rats were anesthetized with ketamine and treated
with heparin (100 U). A midline incision was made, and the aorta was
cannulated below the left kidney. The submesenteric artery and
suprarenal aorta were clamped, and the left kidney was flushed with 10
mL of perfusion solution that contained 0.2% type I
collagenase (Sigma). The kidney was removed, and the inner
medulla was minced and then incubated in 0.2%
collagenase at 37°C for 60 minutes, with mixing every 5
to 10 minutes. At the end of the incubation period, 1.5 vol of
distilled water was added and the suspension was filtered through a
250-µm nylon mesh. The resulting suspension was centrifuged,
and the pellet was washed twice with perfusion
solution.13
Suspensions of Thick Ascending Limbs
Rats were anesthetized as described above. Kidneys were
removed and placed in perfusion solution at 4°C. The outer medulla
was minced into 1-mm pieces. Tissue chunks were incubated for six
10-minute periods in 0.04% type I collagenase with gentle
agitation. At the end of each incubation period, tissue was allowed to
settle for 30 seconds. The supernatant was then removed and stored at
4°C. When incubation was completed, tubules were filtered through a
180-µm mesh and pelleted via centrifugation. The
pellets were washed twice with perfusion solution.14
Cyclic GMP
Tubules were incubated in 95 µL of perfusion solution that
contained 1 mmol/L 3-isobutyl-1-methylxanthine at 37°C for 10
minutes before 5 µL of SPM or vehicle was added to yield
10-7 mol/L, 10-6 mol/L,
or 10-5 mol/L. After 30 minutes, the reaction
was stopped with 100 µL of methanol and the solution was stored at
-80°C. cGMP was determined with a radioimmunoassay (Biomedical
Technologies). On the day of the assay, samples were
centrifuged, the supernatant was transferred to another tube
that was dried in a Savant dryer (Forma Scientific), and the pellet was
reconstituted in 110 µL of sodium acetate buffer. cGMP standards were
treated similarly to the samples. Protein was measured with Coomassie
blue G-250 reagent (Pierce).
Oxygen Consumption
Tubules were incubated at 37°C to eliminate the bubbles caused
when cold solution is added to the oxygen consumption
(QO2) chamber and then warmed.
QO2 was measured in a sealed chamber
with a small injection port by a Clark-type electrode.15
Compounds were added to the suspension as indicated in the text.
QO2 was calculated from the decrease
in oxygen tension with time. Protein was measured with Coomassie blue
G-250 reagent (Pierce).
Statistics
Values are reported as mean±SEM. Two-way ANOVA for repeated
measures, paired t test, and Student's t test
were used to test for significant differences as appropriate.
| Results |
|---|
|
|
|---|
|
We also tested for a difference in the ability of NTG, a chemically
distinct NO donor, to inhibit transport. JCl by
thick ascending limbs from DS rats increased 12.1±16.4% when 1
µmol/L NTG was added to the bath (
+13.0±16.8 pmol ·
mm-1 · min-1,
n=8), whereas the same concentration of NTG inhibited
JCl by thick ascending limbs from DR rats by
26.6±5.1% (
-32.5±6.2 pmol ·
mm-1 · min-1, n=5,
P<0.03 versus DS; Figure 2).
Similar to SPM, a larger concentration of NTG inhibited
JCl by thick ascending limbs to the same extent
in both strains. Basal rates of transport did not differ between
strains.
|
It has been reported that in primary cultures of inner medullary collecting duct cells from prehypertensive DS, Na+ transport is greater than in monolayers from DR6 ; thus, we investigated the effect of SPM on basal QO2 as an index of active transport by suspensions of inner medullary collecting duct cells (Figure 3). Basal QO2 was 144.5±27.5 nmol/mg protein per min in DR (n=7) and 153.8±18.0 nmol/mg protein per min in DS (n=9) (P>0.80). When suspensions of DR inner medullary collecting ducts were treated with 10-5mol/L SPM, QO2 decreased to 118.4±28.9 nmol · mg-1 · min-1 · (P<0.02). When the concentration of SPM was increased to 10-4 mol/L, QO2 fell to 88.4±22.5 nmol · mg-1 · min-1 (P<0.001). After 10-3 mol/L SPM was added, QO2 decreased to 74.4±20.7 nmol · mg-1 · min-1 (P<0.001). When suspensions of inner medullary collecting duct cells from DS were treated with 10-5, 10-4, and 10-3 mol/L SPM, QO2 decreased from 153.8±18.0 to 118.7±12.5 (P>0.01), 90.5±12.5 (P<0.005), and 77.8±14.3 nmol/mg protein per min, respectively (P<0.001).Thus, no statistically significant difference existed between the effects of SPM in the 2 strains of rats.
|
In separate experiments, we examined ouabain-sensitive QO2 and whether SPM inhibited only transport-related QO2. Tubules from DR consumed oxygen at a rate of 107.9±14.7 nmol/mg protein per min. When DR were treated with 1 mmol/L ouabain, QO2 decreased by 40.8±8.7 to 67.9±7.0 nmol · mg-1 · min-1 (n=9). When SPM (1 mmol/L) was added in the presence of ouabain, there was no further decrease in QO2 (60.6±5.0 nmol · mg-1 · min-1). Tubules from DS consumed oxygen at a rate of 99.9±20.8 nmol/mg protein per min (not significantly different from DR). When DS was treated with 1 mmol/L ouabain, QO2 decreased by 48.3±12.5 to 51.6±10.2 nmol · mg-1 · min-1 (n=8; not significantly different from DR). When SPM (1 mmol/L) was added in the presence of ouabain, there was no further decrease in QO2 (50.6±9.8 nmol · mg-1 · min-1). These data indicate that (1) the rate of total QO2 does not differ between the 2 strains; (2) ouabain-sensitive QO2, and thus active Na transport, does not differ between the 2 strains; and (3) the effects of SPM appear to be due to only inhibition of Na transport.
Finally, we investigated basal sodium reabsorption (JNa) and the inhibition induced by SPM in isolated perfused cortical collecting ducts from DS and DR (Figure 4). We used 10 µmol/L SPM because this concentration resulted in greater inhibition of JCl by thick ascending limbs in DR than in DS. Basal JNa by cortical collecting ducts from DR was 15.0±3.0 pmol · mm-1 · min-1 (n=6). Basal JNa by cortical collecting ducts from DS was 13.9±1.8 pmol · mm-1 · min-1 (n=5) (not significantly different from DR). When 10 µmol/L SPM was added to the bath, basal JNa decreased equally in both strains. In cortical collecting ducts from DR, JNa fell to 5.7±1.4 pmol · mm-1 · min-1 (P<0.01 versus basal). In cortical collecting ducts from DS, it decreased to 6.1±1.1 pmol · mm-1 · min-1 (P<0.01 versus basal; not significantly different from DR). Controls showed no significant changes with time. Thus, neither basal nor SPM-inhibited JNa differed significantly between the 2 strains.
|
Because NO regulates transport in the kidney via cGMP,16 17 we investigated whether the disparate effect of NO on JCl by thick ascending limbs from DS and DR was the result of differential intracellular cGMP production (Figure 5). Basal cGMP content was 25.6±5.2 (n=14) and 22.0±2.6 (n=11) fmol/µg protein in thick ascending limbs from DR and DS (P>0.90), respectively. cGMP content increased to 42.2±8.3 and 39.6±5.7 (P<0.02 versus basal) fmol/µg protein in thick ascending limbs from DR and DS after treatment with 0.1 µmol/L SPM. cGMP content increased to 89.9±18.8 (P<0.005 versus basal) and to 98.7±12.1 (P<0.001 versus basal) fmol/µg protein in thick ascending limbs from DR and DS after treatment with 1 µmol/L SPM. After treatment with 10 µmol/L SPM, cGMP content of thick ascending limbs from DR and DS was 88.0±16.1 (P<0.005 versus basal) and 104.7±11.4 (P<0.001 versus basal) fmol/µg protein. Thus, SPM increased cGMP content in thick ascending limbs of DS and DR to a similar extent at all concentrations tested, including concentrations that induced different effects on JCl.
|
| Discussion |
|---|
|
|
|---|
The cause of salt-sensitive hypertension is not completely understood.
However, a common abnormality appears to be a defect in renal salt
excretion that can lead to initial volume expansion and hypertension.
Several hormones and factors have been proposed to explain the
differing ability of DS and DR to eliminate a salt
load,18 19 20 21 22 23 including NO.2 4 9 In vivo data
indicate that NO can induce natriuresis and diuresis without
altering glomerular filtration rate or renal blood flow,
which shows that NO directly alters tubular transport.24
This study and others have directly demonstrated that NO inhibits
transport by various nephron segments, including the proximal
tubule,25 thick ascending limb,26 27 cortical
collecting duct,10 and inner medullary collecting
duct.17 In addition, inhibition of NO synthesis results in
salt-sensitive hypertension.8 28 As a result, we tested
whether the response to NO is different in the thick ascending limb and
collecting duct. We found that NO decreased transport in the thick
ascending limb, cortical collecting duct, and inner medullary
collecting duct. However, we only observed a difference in the ability
of NO to inhibit JCl by thick ascending limbs
from DS and DR. SPM at 10 µmol/L reduced chloride reabsorption
by only 15% in DS versus 38% for DR. This concentration of SPM will
provide
50 nmol/L NO.10 A higher concentration of NO
inhibited JCl to the same extent in thick
ascending limbs from both strains. To ensure that the difference in the
sensitivity of JCl to NO donated by SPM was due
to NO and not artifactual, we also tested for a difference in the
ability of NTG, a chemically distinct NO donor, to inhibit transport.
JCl by thick ascending limbs from DS increased
slightly when 1 µmol/L NTG was added to the bath, whereas
JCl by thick ascending limbs from DR was
inhibited by this concentration of NTG by 35%. Like SPM, a greater
concentration of NTG inhibited chloride absorption by thick ascending
limbs to the same extent in both strains. Thus, the defect that renders
Dahl rats salt-sensitive may be due in part to the diminished response
of the thick ascending limb to NO.
Our results may provide an explanation for the in vivo data that shows that salt sensitivity in DS can be corrected with L-arginine.2 9 These reports imply that the defect is due to reduced production of NO. However, they can also be explained by a decreased response to NO, as indicated by our data that shows that if the concentration of NO is high enough, there is no difference in its ability to inhibit chloride absorption by thick ascending limbs. Our findings appear to be at odds with reports implicating the kallikrein/kinin system20 and 20-HETE.21 However, both kinins and arachidonic acid metabolites may affect the endogenous NO-generating system of the thick ascending limb.27 Kinins are known to stimulate the release of NO in the kidney,24 whereas 20-HETE purportedly counters the effects of NO. Thus, the diminished ability of NO to reduce chloride transport in the thick ascending limb may be due to increased production of a factor that counters its action, such as 20-HETE.
It is difficult to develop a rational explanation for a link between NO and dopamine19 22 or atrial natriuretic factor (ANF),23 which have also been implicated in salt-sensitive hypertension in the Dahl rat by other investigators. However, note that Appel and Dunn,23 who reported that collecting ducts from DS produce less cGMP in response to ANF than tubules from DR, found a difference only at a concentration of 1 µmol/L ANF, which is not in the physiological range.
Our data indicate that at least part of the defect responsible for salt-sensitive hypertension in the DS may be due to an increase in NaCl absorption by the thick ascending limb. These data are consistent with reports that show that JCl by the loop of Henle is greater in DS than in DR 4 5 29 and also with in vitro microperfusion studies that showed no difference in cortical collecting duct Na absorption between the 2 strains.30 Interestingly, the thick ascending limb has been implicated in development of hypertension in the Milan hypertensive rat, which shows an increase in Na/K/2 Cl cotransport31 and Na,K-ATPase 32 compared with normotensive strains. We did not study the concentration-dependent response of the cortical collecting duct, because rats used in these experiments must be treated with DOC acetate. Consequently, a differential effect or the lack of a differential effect of NO on this segment cannot be unambiguously interpreted.
In contrast to the data that show that the thick ascending limb is involved in salt-sensitive hypertension in the Dahl rat, Husted et al6 reported that cultured inner medullary collecting duct cells from DS reabsorb more Na than those from DR. We found no difference in ouabain-sensitive QO2 (a measure of Na transport) by inner medullary collecting ducts from DS and DR. Similarly, we found no difference in the ability of NO to inhibit QO2. The explanation for the difference between our results and the results from Husted and colleagues may be that we studied freshly isolated tubules, whereas Husted et al6 studied cultured cells. Culture conditions may affect DS inner medullary collecting duct cells differently from DR. Culture conditions can alter the phenotype, and various types of cells are often affected differently when culture conditions are changed.33 Finally, because the Dahl rat is an inbred strain, substrains may have developed because of inbreeding at different locations by different vendors. Dahl rat substrains might have different causes of hypertension. Recently, Dahl rats from Harlan were outbred, and at least 2 substrains have been reported34 ; thus, the exact nature of the defect may depend on the vendor and generation number.
Along the nephron, NO acts via generation of cGMP.16 17 Consequently, we tested whether cGMP production by thick ascending limbs differed between the 2 strains. We found that cGMP production became saturated at a concentration of SPM that did not maximally inhibit transport. These data indicate that either (1) NO is not acting via cGMP to inhibit transport or (2) cGMP degradation is different between the 2 strains. In our experiments, phosphodiesterase activity was inhibited by 3-isobutyl-1-methylxanthine; therefore, we cannot eliminate the latter possibility. In addition, we found no difference between basal and NO-stimulated cGMP production. These data indicate that either the defect may reside at some step in the second messenger cascade beyond cGMP, such as at the level of cGMP-dependent protein kinase; NO may activate a different second messenger cascade; or an intrinsic defect exists in either the Na/K/2 Cl cotransporter or Na,K-ATPase. Additional investigation is required to resolve this issue.
In conclusion, we found that basal chloride reabsorption is not significantly different in the thick ascending limb of salt-sensitive and salt-resistant Dahl rats and that NO-induced inhibition of chloride reabsorption is deficient in this model. Because cGMP production was the same in both strains, the abnormality may reside at the level of cGMP-dependent protein kinase or at the site of its phosphorylation. Basal and NO-inhibited transport in the cortical and inner medullary collecting ducts were the same in both strains.
| Acknowledgments |
|---|
Received March 10, 1999; first decision March 29, 1999; accepted May 15, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. B. Silva and J. L. Garvin Angiotensin II-Dependent Hypertension Increases Na Transport-Related Oxygen Consumption by the Thick Ascending Limb Hypertension, December 1, 2008; 52(6): 1091 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Slowinski, P. Kalk, M. Christian, F. Schmager, K. Relle, M. Godes, H. Funke-Kaiser, H.-H. Neumayer, C. Bauer, F. Theuring, et al. Cell-type specific interaction of endothelin and the nitric oxide system: pattern of prepro-ET-1 expression in kidneys of L-NAME treated prepro-ET-1 promoter-lacZ-transgenic mice J. Physiol., June 15, 2007; 581(3): 1173 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Juncos, N. J. Hong, and J. L. Garvin Differential effects of superoxide on luminal and basolateral Na+/H+ exchange in the thick ascending limb Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R79 - R83. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Helms, L. Yu, B. Malik, D. J. Kleinhenz, C. M. Hart, and D. C. Eaton Role of SGK1 in nitric oxide inhibition of ENaC in Na+-transporting epithelia Am J Physiol Cell Physiol, September 1, 2005; 289(3): C717 - C726. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Juncos and J. L. Garvin Superoxide enhances Na-K-2Cl cotransporter activity in the thick ascending limb Am J Physiol Renal Physiol, May 1, 2005; 288(5): F982 - F987. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Varela, M. Herrera, and J. L. Garvin Inhibition of Na-K-ATPase in thick ascending limbs by NO depends on O2- and is diminished by a high-salt diet Am J Physiol Renal Physiol, August 1, 2004; 287(2): F224 - F230. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aviv, N. K. Hollenberg, and A. Weder Urinary Potassium Excretion and Sodium Sensitivity in Blacks Hypertension, April 1, 2004; 43(4): 707 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz, N. J. Hong, D. Wang, and J. L. Garvin Gene Transfer of eNOS to the Thick Ascending Limb of eNOS-KO Mice Restores the Effects of L-Arginine on NaCl Absorption Hypertension, October 1, 2003; 42(4): 674 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Fenton, C.-L. Chou, S. Ageloff, W. Brandt, J. B. Stokes, and M. A. Knepper Increased collecting duct urea transporter expression in Dahl salt-sensitive rats Am J Physiol Renal Physiol, July 1, 2003; 285(1): F143 - F151. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ortiz, B. A. Stoos, N. J. Hong, D. M. Boesch, C. F. Plato, and J. L. Garvin High-Salt Diet Increases Sensitivity to NO and eNOS Expression But Not NO Production in THALs Hypertension, March 1, 2003; 41(3): 682 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Pallone, Z. Zhang, and K. Rhinehart Physiology of the renal medullary microcirculation Am J Physiol Renal Physiol, February 1, 2003; 284(2): F253 - F266. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz and J. L. Garvin Superoxide stimulates NaCl absorption by the thick ascending limb Am J Physiol Renal Physiol, November 1, 2002; 283(5): F957 - F962. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Szentivanyi Jr., A.-P. Zou, D. L. Mattson, P. Soares, C. Moreno, R. J. Roman, and A. W. Cowley Jr. Renal medullary nitric oxide deficit of Dahl S rats enhances hypertensive actions of angiotensin II Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R266 - R272. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz and J. L. Garvin Role of nitric oxide in the regulation of nephron transport Am J Physiol Renal Physiol, May 1, 2002; 282(5): F777 - F784. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz, N. J. Hong, and J. L. Garvin NO decreases thick ascending limb chloride absorption by reducing Na+-K+-2Cl- cotransporter activity Am J Physiol Renal Physiol, November 1, 2001; 281(5): F819 - F825. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Plato {alpha}-2 And {beta}-adrenergic receptors mediate NE's biphasic effects on rat thick ascending limb chloride flux Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R979 - R986. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz and J. L. Garvin Intrarenal Transport and Vasoactive Substances in Hypertension Hypertension, September 1, 2001; 38(3): 621 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz and J. L. Garvin NO Inhibits NaCl Absorption by Rat Thick Ascending Limb Through Activation of cGMP-Stimulated Phosphodiesterase Hypertension, February 1, 2001; 37(2): 467 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Plato, D. M. Pollock, and J. L. Garvin Endothelin inhibits thick ascending limb chloride flux via ETB receptor-mediated NO release Am J Physiol Renal Physiol, August 1, 2000; 279(2): F326 - F333. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Plato, E. G. Shesely, and J. L. Garvin eNOS Mediates L-Arginine-Induced Inhibition of Thick Ascending Limb Chloride Flux Hypertension, January 1, 2000; 35(1): 319 - 323. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||